Related Experiment Video

Updated: Apr 27, 2026

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

4.5K

Molecular pathways: epigenetic modulation of Wnt-glycogen synthase kinase-3 signaling to target human cancer stem

Yannick D Benoit1, Borhane Guezguez1, Allison L Boyd2

  • 1Stem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|July 10, 2014
PubMed

Insights

Aberrant Wnt signaling drives cancer stem cells (CSCs) via epigenetic dysregulation. Novel chromatin inhibitors may restore normal signaling, offering new cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Aberrant regulation of the Wnt/β-catenin/GSK3 signaling pathway is a hallmark of cancer.
  • This pathway is crucial for the formation and maintenance of cancer stem cells (CSCs), which drive tumor growth.
  • Recent research links epigenetic mechanisms controlling stemness to CSC development and Wnt signaling dysregulation.

Purpose of the Study:

  • To review the critical role of epigenetics in CSC development through abnormal canonical Wnt signaling.
  • To discuss emerging concepts and novel therapeutic strategies targeting this axis.

Main Methods:

  • Literature review of recent studies on Wnt signaling, epigenetics, and cancer stem cells.
  • Analysis of epigenetic mechanisms dysregulating stemness and Wnt pathway.
  • Examination of novel chromatin organization inhibitors.

Main Results:

  • Epigenetic alterations critically contribute to CSC generation by disrupting normal Wnt signaling.
  • Dysregulated Wnt signaling in cancer stem cells is closely tied to epigenetic control of pluripotency and stemness.
  • Novel inhibitors targeting chromatin machinery show potential in restoring Wnt signaling in cancer cells.

Conclusions:

  • Epigenetic mechanisms are central to Wnt-driven CSC development in malignancies.
  • Targeting chromatin organization presents a promising therapeutic avenue to re-regulate Wnt signaling and combat cancer.
  • Further preclinical and clinical studies are warranted for these novel inhibitors.

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K
Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

8.1K

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.0K